Skip to content
About Us
Our Founders & Our Story
Leadership
Advisory Board
Our Team
Our Values
Investors
MicroOrganoSphere
TM
(MOS)
Technology
Precision
Oncology
Colorectal Cancer
Breast Cancer
Immuno-oncology
Drug
Development
Collaborators
News &
Publications
Careers
Contact Us
Menu
Biotech startup using AI to take guesswork out of cancer drug selection raises $70M
Post navigation
Previous Post
Xilis raises $70M to advance precision therapy drug discovery, development
Next Post
A Mubadala-backed biotech is using patient tumor tissue grown in a petri dish to change precision …
vera
View posts by vera
Scroll to top
E-mail
Copy
E-mail
Copy
E-mail
